These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31248946)

  • 1. GestaTIonal TrophoblAstic NeoplasIa Ultrasound assessMent: TITANIUM study.
    Verri D; Pasciuto T; Epstein E; Fruscio R; Mascilini F; Moro F; Scambia G; Valentin L; Testa AC
    Int J Gynecol Cancer; 2019 Sep; 29(7):1216-1220. PubMed ID: 31248946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study.
    Braga A; Paiva G; Ghorani E; Freitas F; Velarde LGC; Kaur B; Unsworth N; Lozano-Kuehne J; Dos Santos Esteves APV; Rezende Filho J; Amim J; Aguiar X; Sarwar N; Elias KM; Horowitz NS; Berkowitz RS; Seckl MJ
    Lancet Oncol; 2021 Aug; 22(8):1188-1198. PubMed ID: 34181884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13.
    Bolze PA; Riedl C; Massardier J; Lotz JP; You B; Schott AM; Hajri T; Golfier F
    Am J Obstet Gynecol; 2016 Mar; 214(3):390.e1-8. PubMed ID: 26433171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doppler-based predictive model for methotrexate resistance in low-risk gestational trophoblastic neoplasia with myometrial invasion: prospective study of 147 patients.
    Qin J; Zhang S; Poon L; Pan Z; Luo J; Yu N; Wang L; Wu X; Cheng X; Xie X; Lu Y; Lu W
    Ultrasound Obstet Gynecol; 2021 May; 57(5):829-839. PubMed ID: 32385928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified? A new retrospective analysis from a nationwide dataset.
    Eysbouts YK; Ottevanger PB; Massuger LFAG; IntHout J; Short D; Harvey R; Kaur B; Sebire NJ; Sarwar N; Sweep FCGJ; Seckl MJ
    Ann Oncol; 2017 Aug; 28(8):1856-1861. PubMed ID: 28459944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors of relapse in low-risk gestational trophoblastic neoplasia patients successfully treated with methotrexate alone.
    Couder F; Massardier J; You B; Abbas F; Hajri T; Lotz JP; Schott AM; Golfier F
    Am J Obstet Gynecol; 2016 Jul; 215(1):80.e1-7. PubMed ID: 26829503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Doppler ultrasound useful for evaluating gestational trophoblastic disease?
    Lin LH; Bernardes LS; Hase EA; Fushida K; Francisco RP
    Clinics (Sao Paulo); 2015 Dec; 70(12):810-5. PubMed ID: 26735221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial.
    Cheng H; Zong L; Kong Y; Wang X; Gu Y; Cang W; Zhao J; Wan X; Yang J; Xiang Y
    Lancet Oncol; 2021 Nov; 22(11):1609-1617. PubMed ID: 34624252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
    Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ
    BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and suggestions for improving the FIGO 2000 staging criteria for gestational trophoblastic neoplasia: A ten-year review of 1420 patients.
    Jiang F; Wan XR; Xu T; Feng FZ; Ren T; Yang JJ; Zhao J; Yang T; Xiang Y
    Gynecol Oncol; 2018 Jun; 149(3):539-544. PubMed ID: 29653688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of distance traveled on disease outcomes in gestational trophoblastic neoplasia.
    Clark LH; Staley SA; Barber EL; Wysham WZ; Kim KH; Soper JT
    Am J Obstet Gynecol; 2016 Aug; 215(2):217.e1-5. PubMed ID: 26875944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and simplification of risk factors in FIGO 2000 scoring system for gestational trophoblastic neoplasia: a 19-year retrospective analysis.
    Weng Y; Liu Y; Benjoed C; Wu X; Tang S; Li X; Xie X; Lu W
    J Zhejiang Univ Sci B; 2022 Mar; 23(3):218-229. PubMed ID: 35261217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
    Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center.
    Gockley AA; Joseph NT; Melamed A; Sun SY; Goodwin B; Bernstein M; Goldstein DP; Berkowitz RS; Horowitz NS
    Am J Obstet Gynecol; 2016 Sep; 215(3):334.e1-6. PubMed ID: 27130239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0-4): study protocol for a prospective, multicentre, randomized trial.
    Jiang F; Mao MY; Xiang Y; Lu X; Guan CL; Jiao LZ; Wan XR; Feng FZ; Ren T; Yang JJ; Zhao J
    BMC Cancer; 2023 Aug; 23(1):784. PubMed ID: 37612621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there uniformity in definitions and treatment of gestational trophoblastic disease in Europe?
    Frijstein MM; Lok CAR; Coulter J; van Trommel NE; Ten Kate-Booij MJ; Golfier F; Seckl MJ; Massuger LFAG
    Int J Gynecol Cancer; 2019 Jan; 29(1):108-112. PubMed ID: 30640691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of chest CT scan in gestational trophoblastic neoplasia with lung metastasis].
    Cheng Y; Ma FH; Wang XR; Le XN; Zhang GF; Lu X
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):384-389. PubMed ID: 29961280
    [No Abstract]   [Full Text] [Related]  

  • 18. Uterine artery pulsatility index and serum BMP-9 predict resistance to methotrexate therapy in gestational trophoblastic neoplasia: A cohort study.
    Harvey RA; Elias KM; Lim A; Bercow A; Short D; Horowitz NS; Berkowitz RS; Agarwal R; Seckl MJ
    Curr Probl Cancer; 2021 Feb; 45(1):100622. PubMed ID: 32800689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide.
    Braga A; Mora P; de Melo AC; Nogueira-Rodrigues A; Amim-Junior J; Rezende-Filho J; Seckl MJ
    World J Clin Oncol; 2019 Feb; 10(2):28-37. PubMed ID: 30815369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.